Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Multiple Sclerosis
Location: United States, CT

Clinical Trial Details

Overview

Research Study Summary

Are You Currently Being Treated for a Relapsing Form of Multiple Sclerosis?

Purpose

A research study is currently being conducted to learn about patients' satisfaction and safety of fingolimod compared to other MS drugs.

You may qualify to participate in this study if you:

  • are between the ages of 18 and 65
  • have been diagnosed with a relapsing form of MS
  • have taken a drug used to control your MS symptoms for 6 months or longer

Patient Exclusion Criteria:

  • less than 6 months on a the same treatment

To Learn more
Phase

4

Gender

Both Male and Female

Age

18 to 65 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Diane, Nicci, Chris, Heather, Study Coordinators for Dr. Laurence Radin
Coastal Connecticut Research, LLC
342 Montauk Avenue
New London, CT 06320
Phone: (860) 443-4567
Fax: 860 442-7270

View Map

Research Center Information: Coastal Connecticut Research, LLC

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 170141

Date Last Changed: July 23, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.